Submission Details
| 510(k) Number | K241766 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 20, 2024 |
| Decision Date | August 27, 2025 |
| Days to Decision | 433 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K241766 is an FDA 510(k) clearance for the QMAPP? (Hemo, Hemo Lite, PCM, GO, Hybrid), a Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (Class II — Special Controls, product code MWI), submitted by Fysicon BV (Oss, NL). The FDA issued a Cleared decision on August 27, 2025, 433 days after receiving the submission on June 20, 2024. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.2300.
| 510(k) Number | K241766 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 20, 2024 |
| Decision Date | August 27, 2025 |
| Days to Decision | 433 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | MWI — Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.2300 |